Medtronic Issues Recall for MiniMed Insulin Pumps Over Battery Issues
BDX Upped to Buy by Citi, TNDM Put on Negative Catalyst Watch
Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size
Citi Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $275
Express News | Insulet Corp : Citigroup Raises Target Price to $275 From $250
Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
Insulet's (NASDAQ:PODD) Investors Will Be Pleased With Their Respectable 48% Return Over the Last Five Years
These 4 Measures Indicate That Insulet (NASDAQ:PODD) Is Using Debt Reasonably Well
Insulet Is Maintained at Buy by Canaccord Genuity
CCORF Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $269
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Is Insulet Stock Outperforming the Nasdaq?
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
Insulet Analyst Ratings
Piper Sandler Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $285
Piper Sandler analyst Matthew O'Brien maintains $Insulet(PODD.US)$ with a buy rating, and adjusts the target price from $230 to $285.According to TipRanks data, the analyst has a success rate of 50.7%
Piper Sandler Sticks to Its Buy Rating for Insulet (PODD)
Express News | Insulet Corp : Piper Sandler Raises Target Price to $285 From $230
A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Upstart, Insulet And 2 Other Stocks Executives Are Selling
Insider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD)